Date: 9.11.2012
Researchers have learned how a synthetic molecule destroys complexes that induce allergic responses -- a discovery that could lead to the development of highly potent, rapidly acting interventions for a host of acute allergic reactions.
The study, published online Oct. 28 inNature, was led by scientists at the Stanford University School of Medicine and the University of Bern, Switzerland.
The new inhibitor disarms IgE antibodies, pivotal players in acute allergies, by detaching the antibody from its partner in crime, a molecule called FcR. (Other mechanisms lead to slower-developing allergic reactions.)
"It would be an incredible intervention if you could rapidly disconnect IgE antibodies in the midst of an acute allergic response," said Ted Jardetzky, PhD, professor of structural biology and senior investigator for the study. It turns out the inhibitor used by the team does just that.
The new inhibitor destroys the complex that tethers IgE to the cells responsible for the reaction, called mast cells. Severing this connection would be the holy grail of IgE-targeted allergy treatment.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Charles University - Charles University in Prague
Biotechnology Books no. 14 - 14th page of aour database of biotechnology books
Nano-nutrients can blunt effects of soil contamination, boost crop yields
Antioxidant carbon dot nanozymes alleviate depression in rats by restoring the gut microbiome